75
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Gene expression signatures of mouse bone marrow-derived mesenchymal stem cells in the cutaneous environment and therapeutic implications for blistering skin disorder

, &
Pages 30-45 | Received 31 Mar 2010, Accepted 18 Aug 2010, Published online: 21 Sep 2010

References

  • Jackson L, Jones DR, Scotting P, Sottile V. Adult mesenchymal stem cells: differentiation potential and therapeutic applications. J Postgrad Med. 2007;53:121–7.
  • Phinney DG, Prockop DJ. Concise review. Mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair. Current views. Stem Cells. 2007;25:2896–902.
  • Chen FH, Tuan RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther. 2008;10:223–34.
  • Fibbe WE, Nauta AJ, Roelofs H. Modulation of immune responses by mesenchymal stem cells. Ann NY Acad Sci. 2007;1106:272–8.
  • Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, . Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002;30:42–8.
  • Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, . Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood. 2003;102: 3837–44.
  • Petrie Aronin CE, Tuan RS. Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells. Birth Defects Res C Embryo Today. 2010; 90:67–74.
  • Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC, Lloyd AC, . Spontaneous human adult stem cell transformation. Cancer Res. 2005;65:3035–9.
  • Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S, . Sarcoma derived from cultured mesenchymal stem cells. Stem Cells. 2007;25:371–9.
  • Rubio D, Garcia S, Paz MF, de la Cueva T, Lopez-Fernandez LA, Lloyd AC, . Molecular characterization of spontaneous mesenchymal stem cell transformation. PLoS One. 2008;3:e1398.
  • Baffour R, Pakala R, Hellinga D, Joner M, Okubagzi P, Epstein SE, . Bone marrow-derived stem cell interactions with adult cardiomyocytes and skeletal myoblasts in vitro. Cardiovasc Revasc Med. 2006;7:222–30.
  • Bosnakovski D, Mizuno M, Kim G, Takagi S, Okumura MF, Ujinaga T. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol Bioeng. 2006;93:1152–63.
  • Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res. 2003;18:1842–53.
  • Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 2002;109:337–46.
  • Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell. 2006;126: 677–89.
  • Mansilla E, Marin GH, Drago H, Sturla F, Salas E, Gardiner C, . Bloodstream cells phenotypically identical to human mesenchymal bone marrow stem cells circulate in large amounts under the influence of acute large skin damage: new evidence for their use in regenerative medicine. Transplant Proc. 2006;38:967–9.
  • Badillo AT, Redden RA, Zhang L, Doolin EJ, Liechty KW. Treatment of diabetic wounds with fetal murine mesenchymal stromal cells enhances wound closure. Cell Tissue Res. 2007;329:301–11.
  • Falanga V, Iwamoto S, Chartier M, Yufit T, Butmarc J, Kouttab N, . Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 2007;13:1299–312.
  • Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol. 2008;180:2581–7.
  • Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells. 2007;25:2648–59.
  • Kim SS, Song CK, Shon SK, Lee KY, Kim CH, Lee MJ, . Effects of human amniotic membrane grafts combined with marrow mesenchymal stem cells on healing of full-thickness skin defects in rabbits. Cell Tissue Res. 2009;336: 59–66.
  • Walter MN, Wright KT, Fuller HR, Macneil S, Johnson WE. Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays. Exp Cell Res. 2010;316:1271–81.
  • Yoon BS, Moon JH, Jun EK, Kim J, Maeng I, Kim JS, . Secretory profiles and wound healing effects of human amniotic fluid-derived mesenchymal stem cells. Stem Cells Dev. 2009;19:887–902.
  • Herdrich BJ, Lind RC, Liechty KW. Multipotent adult progenitor cells: their role in wound healing and the treatment of dermal wounds. Cytotherapy. 2008;10:543–50.
  • Tolar J, Ishida-Yamamoto A, Riddle M, McElmurry RT, Osborn M, Xia L, . Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood. 2009; 113:1167–74.
  • Chino T, Tamai K, Yamazaki T, Otsuru S, Kikuchi Y, Nimura K, . Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance. Am J Pathol. 2008; 173:803–14.
  • Conget P, Rodriguez F, Kramer S, Allers C, Simon V, Palisson F, . Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy. 2010;12:429–31.
  • Heinonen S, Mannikko M, Klement JF, Whitaker-Menezes D, Murphy GF, Uitto J. Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa. J Cell Sci. 1999;112:3641–8.
  • Flagler K, Alexeev V, Pierce EA, Igoucheva O. Site-specific gene modification by oligodeoxynucleotides in mouse bone marrow-derived mesenchymal stem cells. Gene Ther. 2008;15: 1035–48.
  • Pirrone A, Hager B, Fleckman P. Primary mouse keratinocyte culture. Methods Mol Biol. 2005;289:3–14.
  • Jeong JA, Hong SH, Gang EJ, Ahn C, Hwang SH, Yang IH, . Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray. Stem Cells. 2005;23:584–93.
  • Brittingham R, Uitto J, Fertala A. High-affinity binding of the NC1 domain of collagen VII to laminin 5 and collagen IV. Biochem Biophys Res Commun. 2006;343:692–9.
  • Tormin A, Brune JC, Olsson E, Valcich J, Neuman U, Olofsson T, . Characterization of bone marrow-derived mesenchymal stromal cells (MSC) based on gene expression profiling of functionally defined MSC subsets. Cytotherapy. 2009;11:114–28.
  • Dalby MJ, Andar A, Nag A, Affrossman S, Tare R, McFarlane S, . Genomic expression of mesenchymal stem cells to altered nanoscale topographies. J R Soc Interface. 2008;5: 1055–65.
  • Ku CH, Johnson PH, Batten P, Sarathchandra P, Chambers RC, Taylor PM, . Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. Cardiovasc Res. 2006;71:548–56.
  • Egusa H, Iida K, Kobayashi M, Lin TY, Zhu M, Zuk PA, . Downregulation of extracellular matrix-related gene clusters during osteogenic differentiation of human bone marrow- and adipose tissue-derived stromal cells. Tissue Eng. 2007;13:2589–600.
  • Fan H, Liu H, Toh SL, Goh JC. Enhanced differentiation of mesenchymal stem cells co-cultured with ligament fibroblasts on gelatin/silk fibroin hybrid scaffold. Biomaterials. 2008;29: 1017–27.
  • Wang G, Bunnell BA, Painter RG, Quiniones BC, Tom S, Lanson NA Jr, . Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc Natl Acad Sci USA. 2005;102: 186–91.
  • Reed CC, Iozzo RV. The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj J. 2002;19:249–55.
  • Kao WW, Funderburgh JL, Xia Y, Liu CY, Conrad GW. Focus on molecules: lumican. Exp Eye Res. 2006;82:3–4.
  • Strazynski M, Eble JA, Kresse H, Schonherr E. Interleukin (IL)-6 and IL-10 induce decorin mRNA in endothelial cells, but interaction with fibrillar collagen is essential for its translation. J Biol Chem. 2004;279:21266–70.
  • Yamamoto T, Eckes B, Krieg T. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1. Biochem Biophys Res Commun. 2001;281:200–5.
  • Schieker M, Pautke C, Haasters F, Schieker J, Docheva D, Bocker W, . Human mesenchymal stem cells at the single-cell level: simultaneous seven-colour immunofluorescence. J Anat. 2007;210:592–9.
  • Kolb M, Margetts PJ, Sime PJ, Gauldie J. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol. 2001;280:L1327–34.
  • Mauviel A, Lapiere JC, Halcin C, Evans CH, Uitto J. Differential cytokine regulation of type I and type VII collagen gene expression in cultured human dermal fibroblasts. J Biol Chem. 1994;269:25–8.
  • Takeda H, Kon A, Ito N, Sawamura D, Takagaki K, Hashimoto I, . Keratinocyte-specific modulation of type VII collagen gene expression by pro-inflammatory cytokines (tumor necrosis factor-alpha and interleukin-1beta). Exp Dermatol. 2005;14:289–94.
  • Shivakumar K, Sollott SJ, Sangeetha M, Sapna S, Ziman B, Wang S, . Paracrine effects of hypoxic fibroblast-derived factors on the MPT-ROS threshold and viability of adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol. 2008; 294:H2653–8.
  • Le JM, Weinstein D, Gubler U, Vilcek J. Induction of membrane-associated interleukin 1 by tumor necrosis factor in human fibroblasts. J Immunol. 1987;138:2137–42.
  • Mauviel A, Heino J, Kahari VM, Hartmann DJ, Loyau G, Pujol JP, . Comparative effects of interleukin-1 and tumor necrosis factor-alpha on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J Invest Dermatol. 1991;96:243–9.
  • Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E, . Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun. 2001;288: 413–9.
  • Maegawa N, Kawamura K, Hirose M, Yajima H, Takakura Y, Ohgushi H. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J Tissue Eng Regen Med. 2007;1: 306–13.
  • Giannouli CC, Kletsas D. TGF-beta regulates differentially the proliferation of fetal and adult human skin fibroblasts via the activation of PKA and the autocrine action of FGF-2. Cell Signal. 2006;18:1417–29.
  • Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, . Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res. 2004;94:678–85.
  • Forte G, Minieri M, Cossa P, Antenucci D, Sala M, Gnocchi V, . Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation. Stem Cells. 2006;24:23–33.
  • Bagutti C, Hutter C, Chiquet-Ehrismann R, Fassler R, Watt FM. Dermal fibroblast-derived growth factors restore the ability of beta(1) integrin-deficient embryonal stem cells to differentiate into keratinocytes. Dev Biol. 2001;231:321–33.
  • Coraux C, Hilmi C, Rouleau M, Spadafora A, Hinnrasky J, Ortonne JP, . Reconstituted skin from murine embryonic stem cells. Curr Biol. 2003;13:849–53.
  • Green H, Easley K, Iuchi S. Marker succession during the development of keratinocytes from cultured human embryonic stem cells. Proc Natl Acad Sci USA. 2003;100:15625–30.
  • Iuchi S, Dabelsteen S, Easley K, Rheinwald JG, Green H. Immortalized keratinocyte lines derived from human embryonic stem cells. Proc Natl Acad Sci USA. 2006;103: 1792–7.
  • Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, Herault O, . The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells. 2007;25:1737–45.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.